What is the price of axitinib/axitinib targeted drug? Price per box and medical insurance coverage in 2025

Axitinib/Axitinib (Axitinib) is an important targeted therapy drug mainly used to treat cancers such as metastatic renal cell carcinoma (mRCC). Since axitinib was approved for marketing in China, it has become one of the commonly used drugs in tumor treatment. Corresponding to its clinical efficacy is the price of the drug, which has an important impact on patients' treatment decisions and treatment effects.

In China, the original drug of axitinib has been successfully included in the Class B medical insurance reimbursement list, which means that patients can enjoy a certain degree of cost reimbursement during the treatment process, thereby alleviating part of the financial burden. Common specifications of axitinib include1mg 14 tablets and 5mg 28 tablets, each box of which sells for about 2,000 yuan. Prices may fluctuate based on a patient's specific treatment plan and medication usage. Considering that axitinib as a targeted drug has a long treatment cycle, the medical insurance reimbursement policy is undoubtedly a positive support for patients' financial pressure.

Compared with the Chinese market, the price difference of axitinib in the international market is large. In developed countries such as Europe and the United States, the price of the original version of axitinib is relatively high, usually around RMB 6,000. The price difference is closely related to local drug pricing policies, production costs, and differences in the medical insurance system. In addition, because axitinib is an innovative drug, imported drugs are usually more expensive, which also affects the financial burden on patients.

In order to reduce patients’ medication costs, generics of axitinib are gradually being launched around the world. Major generic drug producing countries include India, Bangladesh and Laos. These generic drugs are identical in ingredients to the original drugs and undergo strict quality control to ensure that their efficacy and safety are equivalent to those of the original drugs. Compared with original drugs, generic drugs are more affordable. Taking the Indian, Bangladeshi and Laos versions as examples, their prices are usually around 1,000 yuan. Prices may vary due to exchange rate fluctuations, but generic drugs undoubtedly provide patients with a more economical option compared to brand-name drugs.

Reference materials:https://en.wikipedia.org/wiki/Axitinib